$ESRT

Empire State Realty Trust transaction spree set to rage on

Commercial Observer reports Empire State Realty Trust (ESRT) is marketing 1359 Broadway for sale. The 22-story, 486,000 sq ft building could fetch about $225 million, or $463 per sq ft, with no attached debt. It is 95% leased, including SLCE Architects and Infinium Wall Systems. ESRT recently bought Midtown land and agreed to other acquisitions.

Original reporting
Published Jul 24, 2026, 4:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 24, 2026, 4:56 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Empire State Realty Trust transaction spree set to rage on — source image
Decision brief

The 30-second read

$ESRTNeutralMed
01

Why it matters

If 1359 Broadway sells near the reported $225 million level, ESRT could realize gains, reduce office exposure, and potentially fund further non-office acquisitions. However, the article does not confirm a binding agreement or closing timeline.

02

Market read

Transaction marketing for a large, highly leased Midtown office asset is a tangible catalyst for ESRT’s portfolio and capital allocation narrative.

03

What to watch

Final sale price versus the reported $225 million expectation, buyer financing terms, and whether ESRT’s other announced acquisitions/sales change capital allocation priorities.

Relevance 6/10Novelty 6/10Timing: current listing/marketing news, before any confirmed closing or bid deadline

Background

The piece frames Tony Malkin’s strategy to diversify ESRT away from office buildings toward multifamily and retail, citing multiple recent transactions.

Company-level read

Ticker impact

$ESRTNeutralMedium confidence
Context

ESRT is marketing 1359 Broadway for sale, with a reported potential $225 million price and no attached debt, signaling a portfolio shift.

Expected impact

Moderate upside bias if the market views the sale as de-risking and accretive, but magnitude depends on final price and timing.

Evidence & confidence

The article provides concrete sale marketing details (asset size, reported price range, 95% occupancy, no debt) but no confirmation of execution or terms beyond a listing source.

Market effects

Highlights ongoing office-asset monetization and balance-sheet de-levering themes in NYC commercial real estate.

NYC Garment District and Midtown office liquidity remains active, with large blocks marketed for sale.

Limited direct global impact; primarily a US REIT portfolio and transaction-flow signal.

Counterpoint

Marketing does not guarantee a sale; if pricing expectations are too high, the asset could linger and pressure sentiment toward office REITs.

Key entities

  • Empire State Realty Trust

    Subject REIT marketing 1359 Broadway for sale; also referenced in prior acquisitions and a prior sale/contract.

  • 1359 Broadway

    22-story, 486,000-square-foot Garment District office property marketed for sale; reported potential $225 million and no attached debt.

  • Newmark

    Advisory team leading the property’s marketing.

Related articles

$ESRTMed

Declining Empire State Building Visits Drive Q2 Loss for ESRT

New York City’s declines in international tourism over the past year since President Donald Trump assumed office are starting to affect Empire State Realty Trust (ESRT)’s finances. The real estate investment trust (REIT) reported second-quarter funds from operations (FFO) of $57 million, or 21 cents per share, marking a loss of $25.8 million or 15 cents per share from the same period a year ago.

$ESRTMed

ESRT Putting 1359 Broadway Up for Sale, Seeking $225M

Empire State Realty Trust (ESRT) is marketing its mixed-use property at 1359 Broadway for sale, seeking about $225 million, according to sources cited by Commercial Observer. The 486,000 sq ft, 22-story office and retail building is about 95% leased. Recent leases include Infinium Wall Systems and ESRT deals in Q2 2025. No debt encumbers the property.

$RKLBMedAI 8/10

Rocket Lab (RKLB) Won a Major Space Force Contract. Now It Has to Prove Neutron

Rocket Lab (NASDAQ:RKLB) said Aug. 4 it won a $397 million U.S. Space Force contract under the SB-AMTI program to develop, launch and operate Flatellite satellites for airborne target tracking. The work depends on Rocket Lab’s Neutron rocket, whose first flight has been delayed to late 2026 after a Stage 1 tank failure. Rocket Lab reported Q1 FY2026 revenue of $200.3 million.

$DVHighAI 9/10

DoubleVerify Shares Rally After Nielsen Agrees to $2.15 Billion Takeover

DoubleVerify (NYSE:DV) shares rose about 13.6% premarket after Nielsen Holdings agreed to buy DV in an all-cash deal valued at about $2.15 billion. DV shareholders will receive $13.60 per share, a 30% premium to the 60-day VWAP. The boards approved; closing is expected in Q1 2027. Several brokerages cut ratings to Hold/Market Perform with targets at $13.60.

$CHTRMed

Tensions flare as $34-billion Charter-Cox cable deal nears finish line

Charter Communications is nearing California PUC approval for its $34.5B purchase of Cox Enterprises, with a vote scheduled next week. Activists are urging stronger conditions on low-income broadband affordability, disaster response, and diversity and equity commitments. Charter says it will invest at least $275M in network upgrades and $30M in outreach, and the FCC previously approved the deal with DEI safeguards.

MedAI 9/10

Nielsen To Buy DoubleVerify For $2.15 Billion In Ad Measurement Deal

Nielsen agreed to buy DoubleVerify in an all-cash deal valued at about $2.15 billion, paying $13.60 per share, a 30% premium to the stock’s 60-day VWAP as of Aug. 5. The boards approved; closing is expected by Q1 2027, subject to approvals. Pro forma revenue is expected to exceed $4 billion.